Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
Nasdaq 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
Nikkei 14,898.50 +414.52 2.86%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,016.40 -46.05 -0.91%
  • Fund Type: Investment Trust
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Biotech Growth Trust PLC/The

+ Add to Watchlist

BIOG:LN

400.0000 GBp 11.0000 2.68%

As of 11:35:07 ET on 05/23/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Biotech Growth Trust PLC/The (BIOG)

Open: 407.5000 High - Low: 407.5000 - 395.0000 Primary Exchange: London
Volume: 245,973 52-Week Range: 242.0000 - 417.0000 Beta vs NBI: 0.7185

ETF Chart for BIOG

No chart data available.
  • BIOG:LN 400.0000
  • 1D
  • 1M
  • 1Y
400.0000
Interactive BIOG Chart

Previous Close

Fund Profile & Information for BIOG

The Biotech Growth Trust PLC is a closed-end fund incorporated in the United Kingdom. The aim of the Fund is to achieve capital appreciation through investment in the worldwide biotechnology industry principally by investing in emerging biotechnology companies.

Inception Date: 1997-06-23 Telephone: +44-20-3008-4910
Managers: RICHARD D KLEMM
Web Site: www.biotechgt.com

Fundamentals for BIOG

NAV (on 2013-05-22) 401.6600
Assets (M) (on 2004-09-30) 28.4000
Shares out (M) 64.22
Market Cap (M) 256.87
% Premium 2.33
Average 52-Week % Premium -0.3557
Fund Leveraged N

Dividends for BIOG

Dividend Type Discontinued
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for BIOG

1-Month +5.35% 1-Year +67.07%
3-Month +21.06% 3-Year +36.59%
Year To Date +40.63% 5-Year +33.18%
Expense Ratio 1.20

Top Fund Holdings for BIOG

Filing Date: 12/31/2012
Name Position Value % of Total
Infinity Pharmaceuticals Inc 710,300 15,289,694 8.348%
Amgen Inc 286,500 15,219,486 8.309%
Gilead Sciences Inc 622,000 14,060,529 7.677%
Alexion Pharmaceuticals Inc 171,200 9,871,779 5.390%
Celgene Corp 202,000 9,777,521 5.338%
Onyx Pharmaceuticals Inc 209,300 9,725,272 5.310%
Medivation Inc 296,000 9,317,945 5.087%
Regeneron Pharmaceuticals Inc 84,000 8,836,666 4.825%
Perrigo Co 117,800 7,536,156 4.115%
Mylan Inc/PA 442,000 7,469,542 4.078%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil